Publication | Closed Access
Insulin Production by Human Embryonic Stem Cells
902
Citations
34
References
2001
Year
Adult Stem CellImmunologyCell Replacement TherapyLineage-specific DifferentiationPancreas TransplantationInsulin SignalingEmbryologyRegenerative MedicineInsulin ProductionInsulin DeliveryStem CellsCell TransplantationCell BiologyIslet TransplantationInduced Pluripotent Stem CellDevelopmental BiologyDiabetesStem Cell ResearchMedicineEmbryonic Stem CellHes Cells
Type 1 diabetes arises from autoimmune loss of pancreatic β‑cells, causing absolute insulin deficiency and dependence on exogenous insulin, while the scarcity of donor pancreas or islet allografts has spurred the search for alternative β‑cell sources. The study aims to assess human embryonic stem (hES) cells as a model for lineage‑specific differentiation toward insulin‑producing β‑cells. Researchers used pluripotent undifferentiated hES cells in both adherent and suspension cultures to induce spontaneous differentiation. Spontaneous differentiation yielded cells with insulin‑producing β‑cell characteristics, high insulin immunostaining, differentiation‑dependent insulin secretion, and expression of other β‑cell markers, validating the hES model as a potential source for future β‑cell replacement therapy.
Type 1 diabetes generally results from autoimmune destruction of pancreatic islet beta-cells, with consequent absolute insulin deficiency and complete dependence on exogenous insulin treatment. The relative paucity of donations for pancreas or islet allograft transplantation has prompted the search for alternative sources for beta-cell replacement therapy. In the current study, we used pluripotent undifferentiated human embryonic stem (hES) cells as a model system for lineage-specific differentiation. Using hES cells in both adherent and suspension culture conditions, we observed spontaneous in vitro differentiation that included the generation of cells with characteristics of insulin-producing beta-cells. Immunohistochemical staining for insulin was observed in a surprisingly high percentage of cells. Secretion of insulin into the medium was observed in a differentiation-dependent manner and was associated with the appearance of other beta-cell markers. These findings validate the hES cell model system as a potential basis for enrichment of human beta-cells or their precursors, as a possible future source for cell replacement therapy in diabetes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1